Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Feb 14 2025 | Daxor’s Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment Industry News In The News Industry Read More Feb 13 2025 | New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care Industry News In The News Industry Read More Feb 11 2025 | BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM Industry News In The News Industry Read More Feb 11 2025 | Cardio-Oncology and Heart Failure Highlighted in the February 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More Feb 10 2025 | Where Science Meets Innovation: Why You Should Publish with JCF-Intersections HFSA News Journal of Cardiac Failure Read More Pagination First page « First Previous page ‹ Previous … Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Page 30 Page 31 Page 32 … Next page Next › Last page Last »
Feb 14 2025 | Daxor’s Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment Industry News In The News Industry Read More
Feb 13 2025 | New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care Industry News In The News Industry Read More
Feb 11 2025 | BEYONTTRA™ (acoramidis), the First Near Complete TTR Stabilizer (≥90%), Approved by the European Commission to Treat ATTR-CM Industry News In The News Industry Read More
Feb 11 2025 | Cardio-Oncology and Heart Failure Highlighted in the February 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More
Feb 10 2025 | Where Science Meets Innovation: Why You Should Publish with JCF-Intersections HFSA News Journal of Cardiac Failure Read More
